Cargando…

Effects of toceranib phosphate (Palladia) monotherapy on multidrug resistant lymphoma in dogs

We examined whether multidrug resistant (MDR) canine lymphoma increases gene expression for platelet-derived growth factor receptor α (PDGFRα), vascular endothelial growth factor receptor 2 (VEGFR2), and c-KIT, and whether toceranib phosphate (TOC) has potential as a treatment for MDR canine lymphom...

Descripción completa

Detalles Bibliográficos
Autores principales:	YAMAZAKI, Hiroki, MIURA, Naoki, LAI, Yu-Chang, TAKAHASHI, Masashi, GOTO-KOSHINO, Yuko, YASUYUKI, Momoi, NAKAICHI, Munekazu, TSUJIMOTO, Hajime, SETOGUCHI, Asuka, ENDO, Yasuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Veterinary Science 2017
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559368/ https://www.ncbi.nlm.nih.gov/pubmed/28592719 http://dx.doi.org/10.1292/jvms.16-0457

Ejemplares similares

Hypoxia-activated prodrug TH-302 decreased survival rate of canine lymphoma cells under hypoxic condition
por: Yamazaki, Hiroki, et al.
Publicado: (2017)

Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinoma
por: Musser, Margaret L., et al.
Publicado: (2021)

Toceranib phosphate (Palladia) reverses type 1 diabetes by preserving islet function in mice
por: KISHI, Kazuhisa, et al.
Publicado: (2023)

Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal stromal tumors of dogs
por: Berger, Erika P., et al.
Publicado: (2018)

Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor
por: Halsey, Charles HC, et al.
Publicado: (2014)

Feline restrictive orbital myofibroblastic sarcoma treated with toceranib phosphate (Palladia) as adjuvant chemotherapy: A case study of one cat
por: Komatsu, Hiroyuki, et al.
Publicado: (2023)

Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014–2017)
por: Musser, Margaret L., et al.
Publicado: (2018)

Assessment of postoperative adjuvant treatment using toceranib phosphate against adenocarcinoma in dogs
por: Yamazaki, Hiroki, et al.
Publicado: (2020)

Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines
por: Baba, Kenji, et al.
Publicado: (2007)

Phase I Dose-Escalation Study of Nimustine in Tumor-Bearing Dogs
por: TAKAHASHI, Masashi, et al.
Publicado: (2014)

Effects of Toceranib Phosphate on Systolic Blood Pressure and Proteinuria in Dogs
por: Tjostheim, S.S., et al.
Publicado: (2016)

Detection of domestic cat hepadnavirus by next-generation sequencing and epidemiological survey in Japan
por: SAKAMOTO, Haruka, et al.
Publicado: (2023)

Seroprevalence of antibodies against severe acute respiratory coronavirus 2 (SARS-CoV-2) in household dogs in Japan
por: ITO, Genta, et al.
Publicado: (2021)

Effects of Toceranib Phosphate on the Hypothalamic‐Pituitary‐Thyroid Axis in Tumor‐Bearing Dogs
por: Hume, K.R., et al.
Publicado: (2017)

Toceranib phosphate-associated nephrotic syndrome in a dog: a case report
por: Remerowski, Shannon M., et al.
Publicado: (2021)

Clinical and histopathological evaluation of 16 dogs with T-zone lymphoma
por: MIZUTANI, Noriyuki, et al.
Publicado: (2016)

Mutation of p53 Gene and Its Correlation with the Clinical Outcome in Dogs with Lymphoma
por: Koshino, A., et al.
Publicado: (2016)

Toceranib phosphate and firocoxib-mediated partial response in a dog with advanced intranasal sarcoma
por: OSADA, Hironari, et al.
Publicado: (2023)

Pulse‐Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs
por: Burton, J.H., et al.
Publicado: (2015)

Long-term survival in a cat with pancreatic adenocarcinoma treated with surgical resection and toceranib phosphate
por: Todd, Johanna E, et al.
Publicado: (2020)

Long-term survival in a dog with primary hepatic neuroendocrine tumor treated with toceranib phosphate
por: ICHIMATA, Masanao, et al.
Publicado: (2021)

Serum Amyloid A Promotes Invasion of Feline Mammary Carcinoma Cells
por: TAMAMOTO, Takashi, et al.
Publicado: (2014)

Generalized Alopecia with Vasculitis-Like Changes in a Dog with Babesiosis
por: TASAKI, Yumi, et al.
Publicado: (2013)

Combination vinblastine, prednisolone and toceranib phosphate for treatment of grade II and III mast cell tumours in dogs
por: Olsen, Jaime A., et al.
Publicado: (2018)

A Multi-Institutional Retrospective Analysis of Toceranib Phosphate for Presumed or Confirmed Canine Aortic Body Chemodectomas
por: Coto, Giovanna M., et al.
Publicado: (2021)

Toceranib phosphate in the management of canine insulinoma: A retrospective multicentre study of 30 cases (2009–2019)
por: Sheppard‐Olivares, Sabina, et al.
Publicado: (2022)

The Regulation of the Expression of ABCG2 Gene through Mitogen-Activated Protein Kinase Pathways in Canine Lymphoid Tumor Cell Lines
por: TOMIYASU, Hirotaka, et al.
Publicado: (2013)

Plasma Transferrin Concentration as a Nutritional Marker in Malnourished Dogs with Nutritional Treatment
por: NAKAJIMA, Mayumi, et al.
Publicado: (2013)

Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines
por: ASADA, Hajime, et al.
Publicado: (2015)

Characterization of receptor tyrosine kinase activation and biological activity of toceranib phosphate in canine urothelial carcinoma cell lines
por: Korec, Daniela I., et al.
Publicado: (2021)

Molecular epidemiological study of gammaherpesvirus in domestic cats in Japan
por: TATENO, Morihiro, et al.
Publicado: (2017)

Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer
por: Maeda, Shingo, et al.
Publicado: (2022)

Comprehensive analysis of miRNA and protein profiles within exosomes derived from canine lymphoid tumour cell lines
por: Asada, Hajime, et al.
Publicado: (2019)

Prognostic Analyses on Anatomical and Morphological Classification of Feline Lymphoma
por: SATO, Hirofumi, et al.
Publicado: (2014)

Assessment of severity and changes in C-reactive protein concentration and various biomarkers in dogs with pancreatitis
por: SATO, Toru, et al.
Publicado: (2016)

Changes in gene expression profiles and cytokine secretions in peripheral monocytes by treatment with small extracellular vesicles derived from a canine lymphoma cell line
por: TANI, Akiyoshi, et al.
Publicado: (2022)

Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated dose
por: Bernabe, Luis Feo, et al.
Publicado: (2013)

Transcriptome of Two Canine Prostate Cancer Cells Treated With Toceranib Phosphate Reveals Distinct Antitumor Profiles Associated With the PDGFR Pathway
por: Kobayashi, Priscila E., et al.
Publicado: (2020)

Detection of circulating tumor cells using GeneScan analysis for antigen receptor gene rearrangements in canine lymphoma patients
por: HIYOSHI-KANEMOTO, Saaya, et al.
Publicado: (2016)

Intestinal Protease-Activated Receptor-2 and Fecal Serine Protease Activity are Increased in Canine Inflammatory Bowel Disease and May Contribute to Intestinal Cytokine Expression
por: MAEDA, Shingo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cossck9i63c79vu4k4u1gl7m39